- To demonstrate the superiority of glimepiride and metformin free combination in comparison
to glimepiride or metformin alone in terms of Hb1Ac reduction during a 24-week treatment
period in patients with type 2 diabetes mellitus.
Secondary Objectives:
- To assess the effects of the free combination of glimepiride and metformin in comparison
- Percentage of patients reaching HbA1c < 6. 5%
Minimum age: 18 Years.
Maximum age: 78 Years.
Gender(s): Both.
Investigational Site Number 01206, Algeries, Algeria
Investigational Site Number 01203, Oran 31000, Algeria
Investigational Site Number 01205, Setif 19000, Algeria
Investigational Site Number 17003, El Espinal, Colombia
Investigational Site Number 170001, Manizales 170, Colombia
Investigational Site Number 81801, Cairo, Egypt
Investigational Site Number 81802, Cairo, Egypt
Investigational Site Number 81803, Cairo, Egypt
Investigational Site Number 32001, Guatemala, Guatemala
Investigational Site Number 32002, Guatemala, Guatemala
Investigational Site Number 32003, Guatemala, Guatemala
Investigational Site Number 32004, Guatemala, Guatemala
Investigational Site Number 356001, Bangalore 560043, India
Investigational Site Number 356002, Bangalore 560052, India
Investigational Site Number 356006, Ernakulam, India
Investigational Site Number 356003, Indore 452010, India
Investigational Site Number 356009, Lucknow 226003, India
Investigational Site Number 356010, Mumbai, India
Investigational Site Number 356007, Nashik 422002, India
Investigational Site Number 356008, Pune 411007, India
Investigational Site Number 356005, Varanasi, India
Investigational Site Number 364001, Tehran 1411413137, Iran, Islamic Republic of
Investigational Site Number 364002, Tehran 1666694516, Iran, Islamic Republic of
Investigational Site Number 36403, Tehran, Iran, Islamic Republic of
Investigational Site Number 42201, Beirut, Lebanon
Investigational Site Number 42202, Beirut, Lebanon
Investigational Site Number 42203, Chouf, Lebanon
Investigational Site Number 422004, Hazmieh, Lebanon
Investigational Site Number 484002, Guadalajara 44340, Mexico
Investigational Site Number 484003, Guadalajara 44670, Mexico
Investigational Site Number 643003, Moscow 119002, Russian Federation
Investigational Site Number 643002, Saratov 410012, Russian Federation
Investigational Site Number 643001, St.-Petersburg, Russian Federation
Investigational Site Number 710-001, Durban 4092, South Africa
Investigational Site Number 710-002, Durban 4091, South Africa
Investigational Site Number 78803, La Marsa 2070, Tunisia
Investigational Site Number 78804, La Marsa 2070, Tunisia
Investigational Site Number 78805, Sfax, Tunisia
Investigational Site Number 78801, Tunis, Tunisia
Investigational Site Number 78802, Tunis, Tunisia
Investigational Site Number 78806, Tunis, Tunisia
Investigational Site Number 78807, Tunis, Tunisia
Investigational Site Number 792-004, Adana, Turkey
Investigational Site Number 792-003, Antalya 07070, Turkey
Investigational Site Number 792-001, Istanbul 34722, Turkey
Investigational Site Number 792-006, Istanbul 34890, Turkey
Investigational Site Number 792-002, Kutahya, Turkey
Investigational Site Number 792-005, Sivas 58140, Turkey
Investigational Site Number 804001, Kyiv 02175, Ukraine
Investigational Site Number 804002, Kyiv 04114, Ukraine
Investigational Site Number 804003, Zaporozhye, Ukraine
Investigational Site Number 784-001, Dubai, United Arab Emirates
Investigational Site Number 784-002, Dubai, United Arab Emirates
Investigational Site Number 784-003, Dubai, United Arab Emirates
Investigational Site Number 784-004, Sharjah 46458, United Arab Emirates